Role of Sepsis Markers as Potential Biomarkers for Inflammatory Bowel Disease
Authors:
- 11 August 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
Abstract
Goals: This study aimed to investigate whether sepsis markers act as biomarkers of ulcerative colitis (UC) and Crohn’s disease (CD). Background: The identification of noninvasive biomarkers for inflammatory bowel disease (IBD) is advantageous. This prospective observational study investigated whether the sepsis markers, interleukin-6 (IL-6), presepsin (PSEP), procalcitonin (PCT), and pentraxin 3 (PTX3), act as biomarkers of UC and CD. Study: Patients with UC or CD underwent endoscopy and assessment of the abovementioned sepsis markers, C-reactive protein (CRP), and leucine-rich alpha 2 glycoprotein (LRG). We prospectively examined the association of these markers with clinical activity and endoscopic scores, including the Mayo endoscopic subscore (MES) and simple endoscopic score for Crohn’s disease (SES-CD). Results: Eighty-eight patients with UC and 49 patients with CD were enrolled. MES significantly correlated with LRG, CRP, IL-6, PSEP, and PTX3 in patients with UC. SES-CD significantly correlated with LRG, CRP, IL-6, and PTX3 in patients with CD. In UC, MES to 3 groups showed significantly higher LRG, CRP, and IL-6 levels than the MES 0 to 1 groups. The LRG, CRP, IL-6, PSEP, and PTX3 levels were significantly higher in the SES-CD ≥3 group than in the SES-CD ≤2 group. Conclusions: IL-6 in UC and IL-6, PSEP, and PTX3 in CD are potential biomarkers. Overall, our findings could promote better management of IBD.Keywords
This publication has 41 references indexed in Scilit:
- Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative ColitisDigestive Diseases and Sciences, 2019
- Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitisJournal of Crohn's and Colitis, 2013
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortalityIntensive Care Medicine, 2010
- Increased Expression of Long Pentraxin PTX3 in Inflammatory Bowel DiseasesDigestive Diseases and Sciences, 2007
- Evaluation of a newly identified soluble CD14 subtype as a marker for sepsisJournal of Infection and Chemotherapy, 2005
- Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsisIntensive Care Medicine, 2002
- Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsisBritish Journal of Surgery, 1994
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993
- National Cooperative Crohn's Disease Study: Results of drug treatmentGastroenterology, 1979